Drugs / CLL1 CAR-NK cell injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06027853 | Sep 2023 → Aug 2026 overdue | acute myeloid leukemia | Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLL1 CAR-NK cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06027853 ↗ |
| Modality | Cell therapy | “CLL1 target CAR iPSC NK cells” NCT06027853 ↗ |